Picard Medical, Inc.

Picard Medical, Inc. (PMI) priced its initial public offering on Sep 2, 2025 at $4.00 per share, within its $3.50–$4.50 range, raising $17M, and listed on NYSE American. At the IPO price its market capitalization was about $289.3M. Winston & Strawn advised the company and Sheppard Mullin advised the underwriters.

Picard Medical, Inc., through SynCardia, manufactures and sells the SynCardia total artificial heart, an implantable device approved by the FDA and Health Canada. It serves as a bridge to heart transplantation for patients with biventricular failure.

Status

IPO

Ticker

PMI

Exchange

NYSE American

Priced

Sep 2, 2025

IPO price

$4.00

Price range

$3.50–$4.50

Raised

$17M

Market cap at IPO price

$289.3M

First filed

Apr 1, 2025

Company counsel

Winston & Strawn

Underwriters' counsel

Sheppard Mullin

Sector

Healthcare

Country / state

AZ

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.